Why are we still so fat?

Obesity's genetic connection was conclusively demonstrated in the 1980s in a series of papers showing that body weight is strongly inherited, almost as strongly as height

Photo: iStock
Photo: iStock
Gina Kolata | NYT
Last Updated : Nov 24 2018 | 10:36 PM IST
Whenever I see a photo from the 1960s or 1970s, I am startled. It’s not the clothes. It’s not the hair. It’s the bodies. So many people were skinny.
 
In 1976, 15 percent of American adults were obese.
 
Now the it’s nearly 40 per cent. Scientists do a lot of hand-waving about our “obesogenic environment” and point to favourite culprits: the abundance of cheap fast foods and snacks; food companies making products so tasty they are addictive; larger serving sizes; the tendency to graze all day.
 

Also Read

Everyone — from doctors to drug companies, from public health officials to overweight people themselves — would love to see a cure, a treatment that brings weight to normal and keeps it there. Why hasn’t anyone discovered one? It’s not for lack of trying.
 
There is just one almost uniformly effective treatment, and it is woefully underused: only about 1 per cent of the 24 million American adults who are eligible get the procedure.
 
That treatment is bariatric surgery, a drastic operation that turns the stomach into a tiny pouch and, in one version, also reroutes the intestines. Their health usually improves anyway. Many with diabetes no longer need insulin. Cholesterol and blood pressure levels tend to fall. Sleep apnea disappears. Backs, hips and knees stop aching. There are not nearly enough surgeons or facilities to operate on all the obese people who might be helped by bariatric surgery, noted Randy Seeley, director of the nutrition research center at the University of Michigan.
 
And many patients and doctors persist in thinking — all evidence to the contrary — that if overweight people really set their minds to it, they could get thin and stay thin.
 
Scientists got an unsparing look at what they were up against 50 years ago, when a clinical researcher at Rockefeller University, Jules Hirsch, did some old-fashioned experiments. He recruited obese people to stay at the hospital and subsist on a 600-calorie a day liquid diet until they reached a normal weight.
 
The subjects lost 100 pounds on average, and they were thrilled. But as soon as they left the hospital, the pounds piled back on.
 
Hirsch and Rudy Leibel, now at Columbia University, repeated the study again and again, with the same result. Eventually, they found that when a very fat person diets down to a normal weight, he or she physiologically comes to resemble a starving person, craving food with an avidity that is hard to imagine. The lesson never really penetrated the popular consciousness. Just a couple of years ago, Kevin Hall, a senior investigator at the National Institute of Diabetes and Digestive and Kidney Diseases, made headlines with a study of contestants from the Biggest Loser television show. They lost enormous amounts of weight, he found, but rarely could keep it off.
 
Obesity’s genetic connection was conclusively demonstrated in the 1980s in a series of papers showing that body weight is strongly inherited, almost as strongly as height.
 
It was beginning to look hopeless for obese people. Then, in 1995, Jeffrey Friedman of Rockefeller University discovered what looked like the equivalent of insulin for diabetes — a molecule he called leptin that is secreted by fat cells and tells the brain how much fat the body has. Leptin signals some sort of master controller in the brain. If a person is too thin — according to what the brain perceives as an acceptable weight — the brain signals that person to eat. In fat people, that controller is set too high: their brains make sure they stay fat.
 
The drug company Amgen paid Rockefeller and Friedman $20 million for rights to leptin, hoping to develop it as an obesity treatment. The idea was to give leptin to obese patients so their brains would think they had too much fat. If it worked, they ought to lose their appetites and drop pounds.
 
To everyone’s chagrin, leptin fizzled. Most people did not respond to leptin injections by losing weight. But leptin was a key to unlocking a complex network of hormones and brain signals that control body weight.
 
The hope now is to figure out how to have the benefits of bariatric surgery without the surgery.
 ©2018 The New York Times News Service


One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Next Story